UpToDate
Official reprint from UpToDate®
www.uptodate.com ©2016 UpToDate®

Evaluation of congenital anomalies of the kidney and urinary tract (CAKUT)

Author
Norman D Rosenblum, MD, FRCP
Section Editors
Tej K Mattoo, MD, DCH, FRCP
Laurence S Baskin, MD, FAAP
Deputy Editor
Melanie S Kim, MD

INTRODUCTION

Congenital anomalies of the kidney and urinary tract (CAKUT) constitute approximately 20 to 30 percent of all anomalies identified in the prenatal period [1]. Routine antenatal ultrasonography during pregnancy detects the majority of CAKUT.

Antenatal screening for CAKUT and the postnatal evaluation of infants diagnosed prenatally with CAKUT are discussed here.

ANTENATAL SCREENING

The majority of renal malformations are detected antenatally because of the widespread use and sensitivity of fetal ultrasonography. In 2002, a prenatal ultrasound was performed in about two-thirds of all live births in the United States. The frequency of congenital anomalies of the kidney and urinary tract (CAKUT) as detected sonographically in unselected populations has been reported to be between 0.1 to 0.7 percent [2-4].

In general, the optimal timing recommended for a screening antenatal ultrasound is between 16 to 20 weeks of gestation because of the following factors at this gestational age:

There is good visualization of anatomy with a high sensitivity in detecting anomalies.

                  

Subscribers log in here

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information or to purchase a personal subscription, click below on the option that best describes you:
Literature review current through: Nov 2016. | This topic last updated: Wed Mar 30 00:00:00 GMT+00:00 2016.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2016 UpToDate, Inc.
References
Top
  1. Dugoff L. Ultrasound diagnosis of structural abnormalities in the first trimester. Prenat Diagn 2002; 22:316.
  2. Madarikan BA, Hayward C, Roberts GM, Lari J. Clinical outcome of fetal uropathy. Arch Dis Child 1988; 63:961.
  3. Livera LN, Brookfield DS, Egginton JA, Hawnaur JM. Antenatal ultrasonography to detect fetal renal abnormalities: a prospective screening programme. BMJ 1989; 298:1421.
  4. Sanghvi KP, Merchant RH, Gondhalekar A, et al. Antenatal diagnosis of congenital renal malformations using ultrasound. J Trop Pediatr 1998; 44:235.
  5. Cohen HL, Cooper J, Eisenberg P, et al. Normal length of fetal kidneys: sonographic study in 397 obstetric patients. AJR Am J Roentgenol 1991; 157:545.
  6. Cohen HL, Kravets F, Zucconi W, et al. Congenital abnormalities of the genitourinary system. Semin Roentgenol 2004; 39:282.
  7. Vanderheyden T, Kumar S, Fisk NM. Fetal renal impairment. Semin Neonatol 2003; 8:279.
  8. Leibovitch L, Kuint J, Rosenfeld E, et al. Short-term outcome among term singleton infants with intrapartum oligohydramnios. Acta Paediatr 2012; 101:727.
  9. POTTER EL. Bilateral renal agenesis. J Pediatr 1946; 29:68.
  10. Mehler K, Beck BB, Kaul I, et al. Respiratory and general outcome in neonates with renal oligohydramnios--a single-centre experience. Nephrol Dial Transplant 2011; 26:3514.
  11. Nicolini U, Fisk NM, Rodeck CH, Beacham J. Fetal urine biochemistry: an index of renal maturation and dysfunction. Br J Obstet Gynaecol 1992; 99:46.
  12. Muller F, Dommergues M, Bussières L, et al. Development of human renal function: reference intervals for 10 biochemical markers in fetal urine. Clin Chem 1996; 42:1855.
  13. Muller F, Dommergues M, Mandelbrot L, et al. Fetal urinary biochemistry predicts postnatal renal function in children with bilateral obstructive uropathies. Obstet Gynecol 1993; 82:813.
  14. Abdennadher W, Chalouhi G, Dreux S, et al. Fetal urine biochemistry at 13-23 weeks of gestation in lower urinary tract obstruction: criteria for in-utero treatment. Ultrasound Obstet Gynecol 2015; 46:306.
  15. Glick PL, Harrison MR, Golbus MS, et al. Management of the fetus with congenital hydronephrosis II: Prognostic criteria and selection for treatment. J Pediatr Surg 1985; 20:376.
  16. Morris RK, Quinlan-Jones E, Kilby MD, Khan KS. Systematic review of accuracy of fetal urine analysis to predict poor postnatal renal function in cases of congenital urinary tract obstruction. Prenat Diagn 2007; 27:900.
  17. Bökenkamp A, Dieterich C, Dressler F, et al. Fetal serum concentrations of cystatin C and beta2-microglobulin as predictors of postnatal kidney function. Am J Obstet Gynecol 2001; 185:468.
  18. Limwongse C, Cassidy SB. Syndromes and malformations of the urinary tract. In: Pediatric Nephrology, 5th ed, Avner ED, Harmon WE, Niaudet P (Eds), Williams & Wilkins, Philadelphia 2004. p.93.
  19. Mandell J, Blyth BR, Peters CA, et al. Structural genitourinary defects detected in utero. Radiology 1991; 178:193.
  20. Josephson S. Suspected pyelo-ureteral junction obstruction in the fetus: when to do what? II. Experimental viewpoints. Eur Urol 1991; 19:132.
  21. Elder JS, Duckett JW Jr, Snyder HM. Intervention for fetal obstructive uropathy: has it been effective? Lancet 1987; 2:1007.
  22. Freedman AL, Johnson MP, Smith CA, et al. Long-term outcome in children after antenatal intervention for obstructive uropathies. Lancet 1999; 354:374.
  23. Fawer CL, Torrado A, Guignard JP. Maturation of renal function in full-term and premature neonates. Helv Paediatr Acta 1979; 34:11.